⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 19, 2024European Journal Of HaematologyOpen Access

Disease and treatment burden of patients with haemophilia entering the explorer6 non‐interventional study

Jerzy Windyga Shashikant Apte Melissa Frei‐Jones Teruhisa Fujii Chuhl Joo Lyu Laura Villarreal‐Martínez Jameela Sathar Oleksandra Stasyshyn Huyen Tran N. I. Zozulya Renée Brown Frandsen Jesper Skov Neergaard Jay Jay Thaung Zaw Johnny Mahlangu

View Full Paper

Ask AI

Bookmark

Share

Abstract

We aimed to characterise baseline disease and treatment burden in a large population with haemophilia A/B, both with (HAwI/HBwI) and without (HA/HB) inhibitors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Windyga et al. (2024) studied this question.

synapsesocial.com/papers/68e5fb6fb6db64358758f2b2 https://doi.org/10.1111/ejh.14277

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Humanistic burden of haemophilia A without inhibitors: A cross‐sectional analysis of the HemoLIFE study2024 · 4 citations
2Mutational landscape, inhibitor development, and health‐care burden in non‐severe haemophilia A: A single‐centre Australian experience2024 · 1 citations
3Impact of inhibitors positivity on treatment patterns and disease burden in Chinese patients with hemophilia: A cross-sectional real-world study2025
4Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDs2024 · 10 citations
5A Study of Clinical Profile and Treatment in Adult Hemophilia Patients with Special Reference to the Inhibitor Levels2024 · 3 citations